Log In
Print
BCIQ
Print
Print this Print this
 

VEDA-1209

  Manage Alerts
Collapse Summary General Information
Company Cureveda LLC
DescriptionSmall molecule activator of nuclear factor (erythroid-derived 2)-like 2 (NFE2L2; NRF2)
Molecular Target Nuclear factor (erythroid-derived 2)-like 2 (NFE2L2) (NRF2)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationInflammatory bowel disease (IBD)
Indication DetailsTreat ulcerative colitis (UC)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today